Convergence Financial’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.39M Buy
9,428
+4,354
+86% +$1.01M 0.19% 77
2026
Q1
$1.24M Sell
5,074
-451
-8% -$105K 0.13% 86
2025
Q4
$1.14M Sell
5,525
-199
-3% -$39.4K 0.17% 73
2025
Q3
$1.06M Sell
5,724
-608
-10% -$104K 0.16% 79
2025
Q2
$967K Buy
6,332
+132
+2% +$20.3K 0.17% 77
2025
Q1
$1.03M Buy
6,200
+1,099
+22% +$172K 0.2% 66
2024
Q4
$738K Sell
5,101
-344
-6% -$53.3K 0.15% 71
2024
Q3
$882K Sell
5,445
-1,664
-23% -$265K 0.19% 66
2024
Q2
$1.04M Buy
+7,109
New +$1.06M 0.27% 53

Other funds holding JNJ

Convergence Financial's JNJ Position: Q2 2026 in Review

Convergence Financial increased its Johnson & Johnson (JNJ) stake by 86% in Q2 2026, buying an estimated $1.01M and bringing the position to 9,428 shares worth $2.39M. The position accounts for 0.19% of the portfolio, ranked #77.

Convergence Financial first reported a position in JNJ in Q2 2024 and has held it in 9 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Convergence Financial held 9,428 shares of Johnson & Johnson worth $2.39M as of Q2 2026.
  • Convergence Financial bought 4,354 Johnson & Johnson shares in Q2 2026, an estimated $1.01M.
  • Johnson & Johnson made up 0.19% of Convergence Financial's portfolio in Q2 2026, its #77 holding.
  • Convergence Financial first reported a position in Johnson & Johnson in Q2 2024 and has held it in 9 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Convergence Financial's 13F filing for Q2 2026, filed 5 Aug 2026.